Vairimorpha (formerly Nosema) apis and V. ceranae are microsporidian pathogens that are of concern for managed honey bee colonies. Multiple treatments have been proposed to be effective in reducing the prevalence and intensity of Vairimorpha spp. infections. Here, we test the efficacy of these products in one lab-based experiment and three field experiments. In the lab experiment, we found no reductions in Vairimorpha spp. prevalence (proportion of individuals infected with Vairimorpha spp.) or intensity (number of Vairimorpha spp. spores per individual), but we did find a decrease in honey bee survival after treatment with Fumagilin-B, Honey-B-Healthy^®, and Nozevit Plus. The first field experiment showed increased Vairimorpha spp. intensity in colonies treated with Fumagilin-B and HiveAlive^® compared to a negative control (sucrose syrup alone). The second field experiment showed a weak reduction in Vairimorpha spp. intensity after 3 weeks post treatment with Fumagilin-B compared to Nozevit. However, Vairimorpha spp. intensity returned to levels comparable to those of other treatment groups after 5 weeks post treatment and remained similar to those of other groups for the duration of the experiment. The final field trial showed no positive or negative effects of treatment with Fumagilin-B or Nosevit on Vairimorpha spp. prevalence or intensity. These findings raise questions regarding the efficacy of the products currently being used by beekeepers to control Vairimorpha spp. We argue that the observed reduction of Vairimorpha spp. is more likely relevant to the phenology of spore prevalence and intensity in honey bee colonies than to chemical treatment.

Numerous studies have documented the negative effects of neonicotinoids on bees; it remains crucial to examine how neonicotinoids affect other non‐target nectar‐feeding insects, such as the monarch butterfly, Danaus plexippus . Wildflowers growing near agricultural areas can be contaminated with neonicotinoids that affect survival or cause sublethal changes to behaviours of nectar‐feeding insects. Nectar residues of imidacloprid and clothianidin found in milkweeds and wildflowers adjacent to agricultural field range from 0 to 72.8 ng/mL. At field‐relevant doses, two neonicotinoids (imidacloprid and clothianidin) were studied for their effects on adult monarch survival, reproduction, flight and behaviour. First, we fed adult monarchs artificial nectar solutions ranging from 15 to 386 ng/mL of imidacloprid and 19 to 531 ng/mL of clothianidin. Neonicotinoid ingestion slightly reduced monarch reproduction but had no significant effects on survival, weight change, or activity levels. Second, we fed monarchs higher clothianidin doses (909 and 4030 ng/mL), that exceed field‐relevant levels by 22 and 99 times. These higher doses reduced monarch nectar consumption, survival, flight performance and reaction time in response to a drop test. Results show that adult monarchs tolerate field‐relevant doses as high as 54 ng/mL for imidacloprid and 75 ng/mL for clothianidin, with minimal lethal or sub‐lethal effects until much higher doses are supplied. We conclude that adult monarchs are more tolerant of ingested clothianidin and imidacloprid than indicated by previous research.

Oxalic acid (OA) is a popular miticide used to control Varroa destructor (Mesostigmata: Varroidae) in western honey bee (Apis mellifera L.) (Hymenoptera: Apidae) colonies. Our aim was to investigate which method of OA application (dribbling, fogging, or vaporizing) was the most effective at reducing V. destructor infestations (Experiment 1) and to improve upon this method by determining the treatment interval that resulted in the greatest V. destructor control (Experiment 2). We used the product Api-Bioxal (97% OA) and maintained 40 honey bee colonies (10/treatment) in both experiments. In Experiment 1, the treatments included (i) dribbling 50 ml of 3% OA solution, (ii) vaporizing 4 g of solid OA, (iii) using an insect fogger supplied with 2.5% OA dissolved in ethyl alcohol, and (iv) an untreated control. After 3 weeks, only the vaporization method reduced V. destructor infestations (from 9.24 mites/100 bees pretreatment to 3.25 mites/100 bees posttreatment) and resulted in significantly increased brood amounts and numbers of adult bees over those of the controls. In Experiment 2, all colonies were treated with 4 applications of OA via vaporization at a constant concentration of 4 g OA/colony. In this experiment, the groups were separated by treatment intervals at either 3-, 5-, or 7-day intervals. We observed that 5- and 7-day treatment intervals significantly reduced V. destructor populations from pretreatment levels over that of the controls and 3-day intervals. Our data demonstrate the efficacy of OA in reducing V. destructor infestation, particularly vaporizing 4 g every 5–7 days as the most effective method of application.

Western honey bees (Apis mellifera) are exposed to pesticides via nectar/honey, pollen and beeswax. The impacts of honey bee exposure to pesticides via pollen or beeswax currently are not considered in pesticide risk assessments. Correspondingly, we developed an in vitro method through which one can expose adult honey bees to pesticide residues in all matrices simultaneously. The design requires modifying in vitro cages to accommodate a pollen paste feeder and beeswax, determining the appropriate concentration of a toxic standard (dimethoate) needed in both matrices to kill 50 % of exposed adult honey bees (positive control), and integrating the test substances into the matrices consistently and evenly. We established five concentrations of dimethoate, a solvent control (acetone) and a negative control for sucrose water, pollen paste, and beeswax. Each dose was tested with three cages, 10 bees/cage, following EPA and OECD guidelines for Tier 1 tests. Mortality was significantly different between bees in the treatment and control groups at 0.1875-3 μg/g dimethoate in sucrose water, 48-192 μg/g in pollen, and 30-120 μg/g in beeswax. We conducted an additional experiment by adding the highest recorded levels of imidacloprid detected in honey (represented by sucrose water), pollen, and beeswax to each matrix as a proof-of-concept for our proposed method. Survival of bees in this worst-case scenario treatment was significantly lower than that in the solvent control group. The addition of pollen and beeswax as matrices for test substance screening will increase the biological relevance of honey bee toxicity tests.